Skip to main content
. 2017 Aug 22;166(3):809–815. doi: 10.1007/s10549-017-4451-x

Table 1.

Patient characteristics

ALND SLND Total p
N 30 176 206
Age at baseline 0.132
 Mean (SD) 58 (13.3) 61.3 (12.6) 60.8 (12.7)
 Median 57.5 62 62
 Range 38, 38 24, 89 24, 89
BMI high 14 (48%) 83 (50%) 97 (50%) 1.000
Final type of surgery M 21 (70%) 72 (41%) 93 (45%) 0.006
Adjuvant Y 17(57%) 32 (18%) 49 (23%) <0.001
Neo adjuvant Y 7 (23%) 3 (2%) 10 (5%) <0.001
Taxane Y 23 (77%) 27 (15%) 50 (23%) <0.001
Targeted (herceptin or TKI) Y 2 (7%) 7 (4%) 9 (4%) 0.855
WB Y 21 (70%) 87 (49%) 108 (50%) 0.059
Regional nodal irradiation Y 19 (63%) 22 (12%) 41 (19%) <0.001
APBI Y 1 (3%) 19 (11%) 20 (9%) 0.346

ALND axillary lymph node dissection, SLNB sentinel lymph node biopsy, BMI body mass index, TKI tyrosine kinase inhibitor, WB whole breast irradiation, APBI accelerated partial breast irradiation